Authors: Liu Q; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Li J; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Zheng H; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Yang S; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Hua Y; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Huang N; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Kleeff J; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, 06120, Halle (Saale), Germany., Liao Q; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China. lqpumc@126.com., Wu W; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China. wuwm@pumch.cn.

Source: Molecular cancer [Mol Cancer] 2023 Feb 07; Vol. 22 (1), pp. 28. Date of Electronic Publication: 2023 Feb 07.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Authors: Vivekanandhan S; Department of Immunology, Mayo Clinic, Jacksonville, FL, 32224, USA., Bahr D; Department of Immunology, Mayo Clinic, Jacksonville, FL, 32224, USA., Kothari A; Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, 249203, India., Ashary MA; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Baksh M; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA., Gabriel E; Department of Surgery, Division of Surgical Oncology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. Gabriel.Emmanuel@mayo.edu.

Source: Molecular cancer [Mol Cancer] 2023 Feb 01; Vol. 22 (1), pp. 23. Date of Electronic Publication: 2023 Feb 01.

Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Authors: Gabandé-Rodríguez E; Departamento de Biología Molecular, Facultad de Ciencias (UAM), Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria del Hospital 12 de Octubre (i+12), Madrid, Spain., Pfeiffer M; Departamento de Biología Molecular, Facultad de Ciencias (UAM), Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain., Mittelbrunn M; Instituto de Investigación Sanitaria del Hospital 12 de Octubre (i+12), Madrid, Spain.; Consejo Superior de Investigaciones Científicas (CSIC), Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.

Source: EMBO molecular medicine [EMBO Mol Med] 2023 Jan 11; Vol. 15 (1), pp. e16301. Date of Electronic Publication: 2022 Nov 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Authors: Wang W; School of Pharmacy, Nantong University, Nantong, China.; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Saeed M; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Zhou Y; School of Pharmacy, Nantong University, Nantong, China., Yang L; School of Pharmacy, Nantong University, Nantong, China., Wang D; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Yu H; State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.; University of Chinese Academy of Sciences, Beijing, China.

Source: The journal of gene medicine [J Gene Med] 2019 Jul; Vol. 21 (7), pp. e3092. Date of Electronic Publication: 2019 May 28.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9815764 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-2254 (Electronic) Linking ISSN: 1099498X NLM ISO Abbreviation: J Gene Med Subsets: MEDLINE

Authors: Hennah L; Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK., Seckl M; Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK e.ghorani@imperial.ac.uk m.seckl@imperial.ac.uk., Ghorani E; Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK e.ghorani@imperial.ac.uk m.seckl@imperial.ac.uk.

Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Mar 06; Vol. 33 (3), pp. 414-419. Date of Electronic Publication: 2023 Mar 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Rare Diseases*, Humans

Authors: Morgado-Palacin L

Source: The Journal of cell biology [J Cell Biol] 2023 Mar 06; Vol. 222 (3). Date of Electronic Publication: 2023 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 0375356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-8140 (Electronic) Linking ISSN: 00219525 NLM ISO Abbreviation: J Cell Biol Subsets: MEDLINE

MeSH Terms: Neoplasms* , Neoplastic Stem Cells* , Immunotherapy*, Humans ; Autoimmunity ; Immunity

Authors: Zhao H; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China., Yin X; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China., Wang L; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China., Liu K; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China., Liu W; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China., Bo L; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China., Wang L; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China. wangli@hrbmu.edu.cn.

Source: Scientific data [Sci Data] 2023 Mar 03; Vol. 10 (1), pp. 119. Date of Electronic Publication: 2023 Mar 03.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101640192 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4463 (Electronic) Linking ISSN: 20524463 NLM ISO Abbreviation: Sci Data Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/therapy , Immunotherapy* , Tumor Microenvironment*, Female ; Humans ; Drug-Related Side Effects and Adverse Reactions ; Prognosis

Authors: Li P; Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China., Liu Y; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China., Liang Y; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China., Bo J; Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China., Gao S; Department of Hematology, The First Hospital of Jilin University, Changchun 130012, China., Hu Y; Center for Bone Marrow Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China., Hu Y; Institute of Hematology, Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan 430022, China., Huang H; Center for Bone Marrow Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China., Huang X; Peking University People's Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China., Jing H; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China., Ke X; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China., Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China., Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China., Lu P; Lu Daopei Institute of Hematology, Beijing 101102, China., Mei H; Institute of Hematology, Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan 430022, China., Niu T; Department of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China., Song Y; The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China., Song Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China., Su L; Department of Hematology, Shanxi Cancer Hospital, Taiyuan 030013, China., Tu S; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China., Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Division of Pediatric Blood Disease Center, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China., Wu D; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou 215006, China., Wang Z; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China., Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China., Ying Z; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China., Yang Q; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China., Zhang Y; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China., Shi F; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China., Zhang B; Institute of Blood and Marrow Transplantation, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100039, China., Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China., Zhang X; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing 400037, China., Zhao M; Department of Hematology, Tianjin First Central Hospital, Tianjin 300192, China., Zhao W; Department of Hematology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Zhao X; Peking University People's Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China., Huang L; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China., Zhu J; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China., Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China., Han W; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China., Liang A; Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.

Source: Cancer biology & medicine [Cancer Biol Med] 2023 Mar 02; Vol. 20 (2).

Publication Type: Journal Article; Practice Guideline

Journal Info: Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN: 2095-3941 (Print) Linking ISSN: 20953941 NLM ISO Abbreviation: Cancer Biol Med Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Lymphoma, Non-Hodgkin*/therapy , Receptors, Chimeric Antigen*, Humans ; Adaptor Proteins, Signal Transducing ; Antigens, CD19 ; Cell- and Tissue-Based Therapy/adverse effects ; Consensus

Authors: Liu M; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Wang X; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Du X; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Key Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China., Wu W; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; OncoC4 Inc., Rockville, MD 20805, USA., Zhang Y; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Department of Immunology and Microbiology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Zhang P; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China., Ai C; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Key Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China., Devenport M; OncoC4 Inc., Rockville, MD 20805, USA., Su J; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; OncoC4 Inc., Rockville, MD 20805, USA., Muthana MM; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Su L; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Laboratory of Viral Pathogenesis and Immunotherapy, Divisions of Virology, Pathogenesis and Cancer and Immunotherapy, Institute of Human Virology and Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Liu Y; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; OncoC4 Inc., Rockville, MD 20805, USA., Zheng P; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; OncoC4 Inc., Rockville, MD 20805, USA.

Source: Science translational medicine [Sci Transl Med] 2023 Mar; Vol. 15 (685), pp. eabm5663. Date of Electronic Publication: 2023 Mar 01.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Immune Checkpoint Inhibitors*, Humans ; Abatacept ; Ipilimumab ; Nivolumab

Authors: Hill JA; Departments of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Electronic address: jahill3@fredhutch.org., Kiem ES; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bhatti A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Liu W; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Keane-Candib J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Fitzpatrick KS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA; Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA., Boonyaratanakornkit J; Departments of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gardner RA; Seattle Children's Research Institute, Seattle, Washington, USA; Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., Green DJ; Departments of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Maloney DG; Departments of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Turtle CJ; Departments of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Smith JM; Seattle Children's Research Institute, Seattle, Washington, USA; Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., Gimferrer I; Immunogenetics/HLA laboratory Bloodworks Northwest, Seattle, Washington, USA., Blosser CD; Departments of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., Jackson SW; Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA; Seattle Children's Research Institute, Seattle, Washington, USA; Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA. Electronic address: shaun.jackson@seattlechildrens.org.

Source: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2023 Mar; Vol. 23 (3), pp. 416-422. Date of Electronic Publication: 2023 Jan 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Hematologic Neoplasms*, Humans ; B-Cell Maturation Antigen ; Antigens, CD19 ; B-Lymphocytes

Authors: Tieniber AD; Perelman School of Medicine, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA., Perez JE; Perelman School of Medicine, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA., Hanna AN; Perelman School of Medicine, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA., DeMatteo RP; Perelman School of Medicine, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA. Ronald.DeMatteo@pennmedicine.upenn.edu.

Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1794.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Gastrointestinal Neoplasms*/therapy, Humans

Authors: Houshyari M; Clinical Oncology Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Taghizadeh-Hesary F; ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Clinical Oncology Department, Iran University of Medical Sciences, Tehran, Iran.

Source: JCO oncology practice [JCO Oncol Pract] 2023 Mar; Vol. 19 (3), pp. 123-124. Date of Electronic Publication: 2022 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

MeSH Terms: Immunotherapy*, Humans ; Biomarkers

Authors: Lipsitt A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Beattie L; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Harstead E; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Li Y; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Goorha S; Baptist Cancer Center, Memphis, Tennessee, USA., Maron G; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Triplett B; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Naik S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Mar; Vol. 70 (3), pp. e30166. Date of Electronic Publication: 2022 Dec 24.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Hematopoietic Stem Cell Transplantation*/adverse effects, Male ; Humans ; Young Adult ; Adult ; T-Lymphocytes ; Neoplasm Recurrence, Local/etiology ; Hematopoietic Stem Cells ; Antigens, CD34 ; Antigens, CD19

Authors: Yang Z; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA. zhifen.yang@gmail.com., Pietrobon V; Kite Pharma Inc., Santa Monica, CA, 90404, USA., Bobbin M; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Stefanson O; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Yang J; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Goswami A; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Alphson B; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Choi H; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Magallanes K; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Cai Q; Kite Pharma Inc., Santa Monica, CA, 90404, USA., Barrett D; Kite Pharma Inc., Santa Monica, CA, 90404, USA., Wang B; Refuge Biotechnologies Inc., Menlo Park, CA, 94025, USA., Qi LS; Department of Bioengineering, Department of Chemical and Systems Biology, Stanford University, ChEM-H, Stanford, CA, 94305, USA. slqi@stanford.edu., Marincola FM; Kite Pharma Inc., Santa Monica, CA, 90404, USA. fmarincola@gmail.com.

Source: Journal of translational medicine [J Transl Med] 2023 Feb 28; Vol. 21 (1), pp. 158. Date of Electronic Publication: 2023 Feb 28.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

MeSH Terms: Neoplasms*/therapy , Receptors, Chimeric Antigen* , Immunotherapy, Adoptive*, B7-H1 Antigen ; CD28 Antigens ; Interleukin-12/genetics ; Ligands ; Drug Delivery Systems

Authors: Zhao X; The First Clinical Medical College of Gansu, University of Chinese Medicine (Gansu Provincial Hospital), 730000, Lanzhou, Gansu, China.; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China.; Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, 730000, Gansu, China.; NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, 730000, Lanzhou, China., Wang Y; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China.; Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, 730000, Gansu, China.; NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, 730000, Lanzhou, China.; The First Clinical Medical College of Lanzhou University, 204 Donggang West Road, 730000, Lanzhou, Gansu, China., Jiang X; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China.; Graduate School, Ning Xia Medical University, 750004, Yinchuan, Ningxia, China., Mo B; The First Clinical Medical College of Gansu, University of Chinese Medicine (Gansu Provincial Hospital), 730000, Lanzhou, Gansu, China.; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China., Wang C; Graduate School, Ning Xia Medical University, 750004, Yinchuan, Ningxia, China., Tang M; The First Clinical Medical College of Gansu, University of Chinese Medicine (Gansu Provincial Hospital), 730000, Lanzhou, Gansu, China.; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China., Rong Y; The First Clinical Medical College of Gansu, University of Chinese Medicine (Gansu Provincial Hospital), 730000, Lanzhou, Gansu, China.; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China., Zhang G; The First Clinical Medical College of Gansu, University of Chinese Medicine (Gansu Provincial Hospital), 730000, Lanzhou, Gansu, China.; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China., Hu M; Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China. 120220903131@lzu.edu.cn., Cai H; General Surgery Clinical Medical Center, Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China. caialonteam@163.com.; Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, 730000, Gansu, China. caialonteam@163.com.; NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, 730000, Lanzhou, China. caialonteam@163.com.; The First Clinical Medical College of Lanzhou University, 204 Donggang West Road, 730000, Lanzhou, Gansu, China. caialonteam@163.com.; Gansu Provincial Hospital, 730000, Lanzhou, Gansu, China. caialonteam@163.com.

Source: BMC cancer [BMC Cancer] 2023 Feb 28; Vol. 23 (1), pp. 194. Date of Electronic Publication: 2023 Feb 28.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/genetics , Neoplasms*/therapy, Humans ; Immunosuppression Therapy ; Liver ; Antigen-Presenting Cells ; Breast ; DNA Modification Methylases ; Inducible T-Cell Co-Stimulator Protein/genetics

Authors: Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Wulf GG; Hämatologie und Medizinische Onkologie, UM Göttingen, Göttingen, Germany., Duell J; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Glass B; Klinik für Hämatologie und Stammzelltransplantation, Helios Clinic Berlin-Buch, Berlin, Germany., van Heteren P; Klinik für Hämatologie und Stammzelltransplantation, Helios Clinic Berlin-Buch, Berlin, Germany., von Tresckow B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Fischer M; Hämatologie und Medizinische Onkologie, UM Göttingen, Göttingen, Germany., Penack O; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Einsele H; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Holtick U; Department of Internal Medicine I, Leukapheresis and Stem Cell Transplant Unit, University Hospital of Cologne, Cologne, Germany., Thomson J; Hämatologie und Medizinische Onkologie, UM Göttingen, Göttingen, Germany., Dreger P; Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Source: Blood advances [Blood Adv] 2023 Feb 28; Vol. 7 (4), pp. 555-559.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/methods , Neutropenia*, Humans ; Leukocyte Count ; Neutrophils ; Hematopoietic Stem Cells

Authors: Snir T; The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel., Philip H; The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel., Gordin M; The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel., Zilberberg A; The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel., Efroni S; The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel. sol.efroni@biu.ac.il.

Source: Scientific data [Sci Data] 2023 Feb 23; Vol. 10 (1), pp. 108. Date of Electronic Publication: 2023 Feb 23.

Publication Type: Dataset; Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101640192 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4463 (Electronic) Linking ISSN: 20524463 NLM ISO Abbreviation: Sci Data Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Receptors, Antigen, T-Cell*/genetics , Receptors, Antigen, T-Cell*/immunology, Animals ; Mice ; T-Lymphocytes/immunology

Transliterated Title: Quelles pathologies immunologiques sont ciblées par la médecine de précision ?

Authors: Blanchard-Rohner G; Unité d'immunologie-vaccinologie pédiatrique, Service de pédiatrie générale, Département de la femme, de l'enfant et de l'adolescent, Hôpitaux universitaires de Genève, 1211 Genève 14., Hofer M; Unité romande d'immuno-rhumatologie pédiatrique, Service de pédiatrie, Centre hospitalier universitaire vaudois, Université de Lausanne, et Département de la femme, de l'enfant et de l'adolescent, Hôpitaux universitaires de Genève, 1211 Genève 14., Garcia-Tarodo S; Unité de neurologie pédiatrique, Service des spécialités, Département de la femme, de l'enfant et de l'adolescent, Hôpitaux universitaires de Genève, 1211 Genève 14.

Source: Revue medicale suisse [Rev Med Suisse] 2023 Feb 22; Vol. 19 (815), pp. 370-373.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN: 1660-9379 (Print) Linking ISSN: 16609379 NLM ISO Abbreviation: Rev Med Suisse Subsets: MEDLINE

MeSH Terms: Precision Medicine* , Immunotherapy*, Phenotype

Authors: Lakomy T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland., Akhoundova D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland., Nilius H; University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Kronig MN; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland., Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland., Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.

Source: Biomolecules [Biomolecules] 2023 Feb 17; Vol. 13 (2). Date of Electronic Publication: 2023 Feb 17.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Cytokine Release Syndrome*/etiology, Humans ; Receptors, Antigen, T-Cell ; Retrospective Studies ; Adrenal Cortex Hormones/therapeutic use ; Treatment Outcome

Authors: Obradovic A; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.

Source: Science (New York, N.Y.) [Science] 2023 Feb 17; Vol. 379 (6633), pp. 654-655. Date of Electronic Publication: 2023 Feb 16.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

MeSH Terms: Immunotherapy*/methods , Neoplasms*/genetics , Neoplasms*/therapy , Precision Medicine*/methods , Single-Cell Analysis* , Gene Expression Regulation*, Humans ; Algorithms ; Proteins/genetics ; Proteins/metabolism ; Regulon